Meningitis vaccine
US4264764A · kind A · utility
3Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 24, 1979 |
| Grant date | Apr 28, 1981 |
| Priority date | — |
| Expiry date | Sep 24, 1999 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/831
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A high molecular weight capsular polysaccharide from H. influenza type b is an effective immunogenic agent against infection caused by the H. influenza type b bacterium.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.